BILCARE ACQUIRES USA BASED PROCLINICAL

Bilcare Ltd has acquired ProClinical Inc. of USA. With this acquisition Bilcare enters the Pharma heartland of USA wherein 40 per cent of world pharma activities take place. Pennsylvania based ProClinical Inc. is in the centre of the pharma corridor of USA. Its USFDA approved facility is spread across 14 acres and is Drug Enforcement Agency (DEA) licensed for controlled substances schedule I V. The pharmaceuticals services offered by ProClinical are Pre/formulation research and development, analytical services including development, clinical batch manufacturing and packaging, distribution of clinical supplies including Interactive voice response system and complete management of controlled drug substances.

Myiris (http://www.myiris.com/newsCentre/newsPopup.php?fileR=20050715120520002&dir=2005/07/15&secID=livenews)